Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

We came across a bullish thesis on Stryker Corporation (SYK) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on SYK.

Stryker Corporation (SYK)’s share was trading at $353.42 as of April 14th. SYK’s trailing and forward P/E were 45.54 and 26.04 respectively according to Yahoo Finance.

PBH currently has a forward P/E ratio of 16.76, while SYK has a forward P/E of 25.04. We also note that PBH has a PEG ratio of 2.39. This metric is used similarly to the famous P/E ratio, but the ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model based on the published strategy of ...

PROX-1 activates the expression of podoplanin (PDPN) in LECs (Pan et al., 2014), and PDPN activates calcium-dependent lectin-like receptor 2 (CLEC-2) in platelets, triggering platelet activation ...

Scientists headed by a team at the University of Tokyo have identified a protein, known as podoplanin (PDPN), that is common to both human and canine mucosal melanoma, and which appears to ...

Podoplanin (PDPN) is a well-conserved, mucin-type transmembrane protein expressed in multiple tissues during ontogeny and in adult animals, ... This non-separation phenotype is also observed in mice ...